en · de · es · fr · pt
glossary-desk.peptides8425.com › Data › Thymosin Beta-4 Fragment Identity — Evidence Review

Thymosin Beta-4 Fragment Identity — Evidence Review

By Editorial Desk · published 2025-10-22 · last reviewed 2025-12-12 · Data

Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2025-12-12. Where a claim depends on a specific study, the study is described rather than over-claimed.

Thymosin Beta-4 Fragment Identity

TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.

Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.

No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.

Identity And Naming Background

Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.

Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.

Tb-500 at a glance

PropertyValueNotes
Molecular massApproximately 4963 Da for full-length thymosin beta-4Value applies to the parent protein; fragment products may differ
AppearanceWhite to off-white lyophilized powderTypical form of supplied synthetic peptide
SolubilityFreely soluble in waterPolar peptide; dissolves readily in aqueous buffer
Storage of dry powder−20 °C, desiccated, protected from lightStandard laboratory practice for peptides
Typical detection methodLiquid chromatography–tandem mass spectrometryUsed in purity testing and anti-doping analysis

Handling, Storage and Analytical Checks

Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.

Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.

Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.

Related pages on this site

Thymosin Beta-4 Fragment Background

Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.

Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.

Storage and Analytical Verification

Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.

Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.

Background from the literature

===== Licensed pharmaceutical manufacturers ===== Heroin and its production and distribution are strictly regulated by government health authorities and subject to international drug control treaties. In countries where medical diamorphine (heroin) is legal, a small number of licensed pharmaceutical manufacturers are authorized to produce diamorphine from morphine, which is derived from legally cultivated opium poppy. All manufacturing and handling are conducted by these licensed companies under close government oversight, operating under stringent national and international regulations. Their activities are monitored by agencies such as the International Narcotics Control Board (INCB), and the entire supply chain—from opium cultivation to the final pharmaceutical product—is subject to quotas, licensing, and detailed reporting requirements to prevent diversion to illicit markets.

== Identification == Fossil dinosaur eggshell fragments can be recognized based on three important traits. Their thickness should be roughly uniform, they are usually slightly curved, and their surface is covered in tiny pores. Less frequently, the concave underside of the eggshell fragment will preserve bumps known as mammillae. Sometimes the embryo had absorbed so much of the calcium that the mammillae need a magnifying glass or microscope to be seen. However, there are many kinds of naturally occurring objects which can resemble fossil eggs. These can fool even professional paleontologists.

The US government responded by adopting a policy of containment, with the goal of stopping the spread of communism. Truman delivered a speech calling for the allocation of $400 million to intervene in the war and unveiled the Truman Doctrine, which framed the conflict as a contest between free peoples and totalitarian regimes. American policymakers accused the Soviet Union of conspiring against the Greek royalists in an effort to expand Soviet influence even though Stalin had told the Communist Party to cooperate with the British-backed government. Enunciation of the Truman Doctrine marked the beginning of a US bipartisan defense and foreign policy consensus between Republicans and Democrats focused on containment and deterrence that weakened during and after the Vietnam War, but ultimately persisted thereafter. Moderate and conservative parties in Europe, as well as social democrats, gave virtually unconditional support to the Western alliance, while European and American Communists, financed by the KGB and involved in its intelligence operations, adhered to Moscow's line, although dissent began to appear after 1956. Other critiques of the consensus policy came from anti-Vietnam War activists, the Campaign for Nuclear Disarmament, and the anti-nuclear movement.

=== Food safety === Faced with the problem of how and what to feed an astronaut in a sealed capsule under weightless conditions while planning for human spaceflight, NASA enlisted the aid of The Pillsbury Company to address two principal concerns: eliminating crumbs of food that might contaminate the spacecraft's atmosphere and sensitive instruments, and assuring absolute absence of disease-producing bacteria and toxins. Pillsbury developed the Hazard Analysis and Critical Control Points (HACCP) concept to address NASA's second concern. HACCP is designed to prevent food safety problems rather than to catch them after they have occurred. The U.S. Food and Drug Administration has applied HACCP guidelines for the handling of seafood, juice, and dairy products.

Sources: en.wikipedia.org

Reference notes

phagocyte Any cell capable of phagocytosis, especially any of various cell types of the immune system which engulf and ingest harmful foreign molecules, bacteria, and dead or dying cells, including neutrophils and macrophages.

I never called Edith Luthien—but she was the source of the story that in time became the chief part of the Silmarillion. It was first conceived in a small woodland glade filled with hemlocks at Roos in Yorkshire (where I was for a brief time in command of an outpost of the Humber Garrison in 1917, and she was able to live with me for a while). In those days her hair was raven, her skin clear, her eyes brighter than you have seen them, and she could sing—and dance. But the story has gone crooked, & I am left, and I cannot plead before the inexorable Mandos. On 16 July 1919, Tolkien was taken off active service, at Fovant, on Salisbury Plain, with a temporary disability pension. On 3 November 1920, Tolkien was demobilized and left the army, retaining his rank of lieutenant.

In 1968, after experiencing HD in his wife's family, Dr. Milton Wexler was inspired to start the Hereditary Disease Foundation (HDF), with the aim of curing genetic illnesses by coordinating and supporting research. The foundation and Wexler's daughter, Nancy Wexler, were key parts of the research team in Venezuela which discovered the HD gene. At roughly the same time as the HDF formed, Marjorie Guthrie helped to found the committee to Combat Huntington's Disease (now the Huntington's Disease Society of America), after her husband, folk singer-songwriter Woody Guthrie died from complications of HD. Since then, support and research organizations have formed in many countries around the world and have helped to increase public awareness of HD. A number of these collaborate in umbrella organizations, like the International Huntington Association and the European HD network. Many support organizations hold an annual HD awareness event, some of which have been endorsed by their respective governments. For example, 6 June is designated "National Huntington's Disease Awareness Day" by the US Senate. Many organizations exist to support and inform those affected by HD, including the Huntington's Disease Association in the UK. The largest funder of research is provided by the Cure Huntington's Disease Initiative Foundation (CHDI).

After a Spanish reconquest, Colombian independence was secured and the Gran Colombia period began in 1819. The new polity experimented with federalism as the Granadine Confederation (1858) and then the United States of Colombia (1863), before becoming a centralised republic in 1886. With the backing of the US and France, Panama seceded from Colombia in 1903, resulting in Colombia's present borders. Beginning in the 1960s, the country has suffered from an asymmetric low-intensity armed conflict and political violence, both of which escalated in the 1990s. Since 2000, there has been improvement in security, stability, and rule of law, as well as economic growth and development. Colombia is recognized for its healthcare system, being the best healthcare in the Americas according to the World Health Organization and 22nd in the world. Its diversified economy is the third-largest in South America, with macroeconomic stability and favorable long-term growth prospects. The country has one of the widest recognitions of LGBT rights, gender equality, animal rights, and human rights, permitting same-sex adoption, same-sex marriage, legality of abortion, legality of euthanasia, and animal rights protections. Colombia is one of the world's seventeen megadiverse countries; it has the highest level of biodiversity per square mile in the world, and second-highest level overall. Its territory encompasses the Amazon rainforest, highlands, grasslands and deserts.

Raicho Kimikage (君影 雷鳥, Kimikage Raichō) Agent of Summer's Guard Candidate, Ruri's fiancé. He's a confident, sometimes arrogant man. Most people consider him weird, but he's kind and devoted to those he respects. He's madly in love with Ruri. Renri Rouo (老鶯 連理, Rōō Renri) Town of Summer doctor and Ayame's fiancé. He is a doctor affiliated with the town's medical practice. Despite his playboy appearance, he is kind and gentle. He wishes to marry Ayame, but there is a big secret between them.

Sources: en.wikipedia.org

Frequently asked questions

Is TB-500 the same as thymosin beta-4?

Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.

Has any regulator approved TB-500 for medical use?

No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.

Why does TB-500 appear in anti-doping literature?

It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.

Is TB-500 identical to thymosin beta-4?

No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.

Network